Health & Biotech
ASX Health Stocks: Amplia begins Phase 2 trial for pancreatic cancer, while Avecho commences Phase 1 of cannabis gel
Health & Biotech
Check Up: ASX biotech comes alive as health stocks tackle international markets
Health & Biotech
MGC Pharma share price soars after CannEpil+ scores UK-first import deal
Health & Biotech
ASX Health Stocks: Cannabis play Cronos scoots 19% higher on merger news, Telix gets FDA nod for clinical trial
Health & Biotech
ASX Health Stocks: HeraMed jumps 11pc on survey results, while Acrux seeks FDA approval for acne gel
Health & Biotech
Creso Pharma expands European footprint with additional hemp seed oil purchase orders
Health & Biotech
Dr Boreham’s Crucible: The reality of IDT Australia actually getting a COVID vaccine in a vial
Health & Biotech
ScoPo’s Powerplays: Profit-taking on the cards for health stocks that have had good runs
Health & Biotech
ASX health stocks: Shares in cancer-fighting company Noxopharm edge higher following its full-year results
Health & Biotech
Rhinomed shares gain another 20pc, after 1 million Rhinoswab order from the Victorian government
Health & Biotech
Epsilon signs deal with Canadian cannabis products powerhouse The Valens Company
Health & Biotech
Exopharm signs deal with Japanese chemical company as LEAP tech promise to accelerate new cancer-beating research
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.